[HTML][HTML] Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
EA Selvaraj, FE Mózes, ANA Jayaswal… - Journal of …, 2021 - Elsevier
Background and Aims Vibration-controlled transient elastography (VCTE), point shear wave
elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic …
elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic …
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal… - Gut, 2022 - gut.bmj.com
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic
fatty liver disease. The aims of this study were to evaluate the individual diagnostic …
fatty liver disease. The aims of this study were to evaluate the individual diagnostic …
Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment
LJM Heyens, D Busschots, GH Koek, G Robaeys… - Frontiers in …, 2021 - frontiersin.org
An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A …
Y Cao, L Xiang, F Qi, Y Zhang, Y Chen, X Zhou - EClinicalMedicine, 2022 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease,
and among the non-invasive tests, controlled attenuation parameter (CAP) and liver stiffness …
and among the non-invasive tests, controlled attenuation parameter (CAP) and liver stiffness …
[HTML][HTML] WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver
G Ferraioli, C Filice, L Castera, BI Choi, I Sporea… - Ultrasound in medicine …, 2015 - Elsevier
Abstract The World Federation for Ultrasound in Medicine and Biology (WFUMB) has
produced these guidelines for the use of elastography techniques in liver disease. For each …
produced these guidelines for the use of elastography techniques in liver disease. For each …
Epidemiology and natural history of non-alcoholic fatty liver disease
Y Fazel, AB Koenig, M Sayiner, ZD Goodman… - Metabolism, 2016 - Elsevier
Non-alcoholic steatohepatitis (NASH) is part of the spectrum of non-alcoholic fatty liver
disease (NAFLD) that leads to progressive liver disease and presents a growing challenge …
disease (NAFLD) that leads to progressive liver disease and presents a growing challenge …
Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement
The Society of Radiologists in Ultrasound convened a panel of specialists from radiology,
hepatology, pathology, and basic science and physics to arrive at a consensus regarding …
hepatology, pathology, and basic science and physics to arrive at a consensus regarding …
Quantitative elastography methods in liver disease: current evidence and future directions
Chronic liver diseases often result in the development of liver fibrosis and ultimately,
cirrhosis. Treatment strategies and prognosis differ greatly depending on the severity of liver …
cirrhosis. Treatment strategies and prognosis differ greatly depending on the severity of liver …
Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study
In patients with compensated advanced chronic liver disease (cACLD), the presence of
clinically significant portal hypertension (CSPH) and varices needing treatment (VNT) bears …
clinically significant portal hypertension (CSPH) and varices needing treatment (VNT) bears …